Studies conducted in xenograft models have elucidated the multi-step neoplastic transformation process of AITL, from acquisition of premalignant epigenetic mutations to the development of disease-specific mutations (“driver-mutations”), such as RhoA G17V. Here, RHOA is linked to angioimmunoblastic T-cell lymphoma.